Long - term resilience

Search documents
Aino Health AB (publ): interim report january-march 2025
Globenewswireยท 2025-05-15 06:30
Core Insights - The first quarter of 2025 has shown increased turnover and positive cash flow despite a challenging market environment characterized by cautious investment appetite and macroeconomic uncertainty [2][3] - Revenues increased by 23% compared to the same period last year, with cash flow turning positive and achieving positive EBITDA [3][9] - The company has made price adjustments leading to some customer relationship terminations, resulting in a reduction of licenses, which will be reflected in the second quarter [2][3] Financial Performance - Total turnover for the period was 7,378 TSEK, up from 5,994 TSEK in the previous year [9] - Profit after financial items improved to -554 TSEK from -2,943 TSEK [9] - Earnings per share remained at -0.0 SEK, consistent with the previous year [9] Operational Developments - Almost all sold licenses are now fully integrated, positively impacting monthly recurring revenue (MRR) [3] - There is increased interest from academic and research institutions in studying the relationship between work ability management, wellbeing, and productivity using the company's data and platform insights [3] Future Outlook - The company expects market conditions to gradually improve towards the summer and the second half of the year [4] - Focus will remain on driving operational excellence, deepening customer relationships, and seizing new opportunities as they arise [4]